Clinical Trials Logo

Patient Participation clinical trials

View clinical trials related to Patient Participation.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06138145 Completed - Pediatric ALL Clinical Trials

Inclusion Appeal Videos and Intent to Register for Pediatric Clinical Trials

Start date: November 17, 2022
Phase: N/A
Study type: Interventional

An informational video about joining a Research Notification Registry is being compared with a version of the video tailored to African/ African American parents, reminding them about the importance of their being included in clinical trials. African/African American parents and caregivers of children under 13 years of age are targeted.

NCT ID: NCT06038435 Completed - Clinical trials for Autism Spectrum Disorder

The Effect of Cognitive Orientation Approach on Daily Occupational Performance With Autism Spectrum Disorder

Start date: September 4, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is by using the Cognitive Orientation Approach on Daily Occupational Performance, which is also supported by the literature and applied by occupational therapists, in children diagnosed with Autism Spectrum Disorder, it is aimed to determine how children's executive function scores and occupational participation change. The main questions it aims to answer are: - Does the Cognitive Orientation Approach on Daily Occupational Performance have an effect on executive functions? - Does the Cognitive Orientation Approach on Daily Occupational Performance have an effect on occupational performance? Participants will: - Evaluations will be applied to all participants - Divided into intervention and control groups - The intervention group will be given "Cognitive Orientation Approach on Daily Occupational Performance" and "Ayres Sensory Integration Therapy" followed up for about 10 weeks. - The control group will be given "Ayres Sensory Integration Therapy" followed up for about 10 weeks. - After 10 weeks, the results between the two groups will be compared. - After the second evaluation, both groups will be followed for 1 month and the same evaluations will be repeated. Researchers will compare intervention and control groups to see executive functions and occupational participation.

NCT ID: NCT05502445 Completed - Sarcopenia Clinical Trials

The Nutritionist's Educational Intervention on the Protein Intake in Hospitalized Elderly People

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

The food intake is often compromised in the elderly, and during hospitalization, dietary restrictions may be imposed, making them more susceptible to the risk of malnutrition and sarcopenia. It is essential to make an early identification of the elderly with low intake and involve them in their self-care. The aims will be assess the influence of the nutritionist's educational action to increase protein intake in elderly patients, to analyze the knowledge on its importance in the prevention of sarcopenia and to identify the prevalence of nutritional risk. This is a field, prospective, correlational, comparative and randomized study. The elderly patients will be randomized into a Control Group and Intervention Group.

NCT ID: NCT05348603 Completed - Clinical trials for Patient Participation

Electronic Health Record Strategies to Promote Diverse Participation in Research

Start date: September 13, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effectiveness of enhanced features in an online patient portal including banners, a chatbot, and direct to patient message and traditional mailed letters on increasing interest in research among online patient portal users.

NCT ID: NCT05229016 Completed - Clinical trials for Patient Participation

Priming and Patient Reported Outcome Measures

Start date: November 9, 2021
Phase: N/A
Study type: Interventional

The objective of the study is to assess which health-related questionnaire is the most accurate and reliable. The hypothesis is that some health-related questionnaires are more reliable than others.

NCT ID: NCT04802512 Completed - Clinical trials for Health Knowledge, Attitudes, Practice

Turkish Version of Telehealth Usability Questionnaire (TUQ)

Start date: March 12, 2021
Phase:
Study type: Observational [Patient Registry]

The Telehealth Usability Questionnaire (TUQ) was developed to evaluate the usability of telehealth applications and services. The Turkish validity and reliability study of the scale, originally in English, has not been conducted before. The aim of this study is to develop the Turkish version of the Telehealth Usability Questionnaire (TUQ), which is a new stability tool, and to report its reliability assessment.

NCT ID: NCT04420871 Completed - Clinical trials for Patient Participation

Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients With Colorectal or Breast Cancer

Start date: December 10, 2018
Phase: Phase 1
Study type: Interventional

A multicenter, randomized, open-label, three-period, and reference-replicated crossover study was conducted in 48 patients with colorectal or breast cancer under fed conditions to assess the bioequivalence between two formulations of capecitabine.

NCT ID: NCT04288362 Completed - Diabetes Mellitus Clinical Trials

Patient Activation Through Community Empowerment/Engagement for Diabetes Management (PACE-D)

PACE-D
Start date: March 25, 2019
Phase: N/A
Study type: Interventional

The study is a non-randomised controlled trial involving an intervention group and a control group. It aims to evaluate the effects of a patient engagement and empowerment model of collaborative care support planning on clinical outcomes of patients with diabetes mellitus as compared to usual care in the primary care setting. It also aims will be to examine the impact of the intervention on patient activation, patient and healthcare provider experience, and healthcare utilisation.

NCT ID: NCT04153266 Completed - Quality of Life Clinical Trials

Oral Epithelial Dysplasia Informational Needs Questionnaire

ODIN-Q
Start date: October 31, 2018
Phase:
Study type: Observational

Background: Oral epithelial dysplasia (OED) is a condition with an increased risk of oral cancer. Due to the current changes in the factors associated with these diseases (because of human papillomavirus), it is expected that those who have no history of smoking or alcohol, young (<50 years old), and white male would be commonly affected. Those individuals require a higher need for information, preferred a more active role in decision-making, and have a longer lifespan than older individuals. There remain no detailed studies of whether the informational needs delivered to patients with OED met their needs or indeed what information such patient may wish. A few tools are available to evaluate the IN of patients with head and neck disorders. However, the items of these instruments were dedicated to a particular disease (e.g. cancer) and hence are not applicable to be used for OED. Project aims: To evaluate the psychometric properties of the Oral Epithelial Dysplasia Informational Needs Questionnaire (ODIN-Q), developed and revised in the preliminary work for the proposed study, in a cohort of patients with OED. Timescale: 19 months. Clinical significance: This questionnaire can be useful in clinical practice. It could help to meet the patient's information needs and plan educational interventions for those showing unmet needs.

NCT ID: NCT03985163 Completed - Opioid-use Disorder Clinical Trials

Patient Reported Outcomes for Opioid Use Disorder

Start date: June 7, 2019
Phase:
Study type: Observational [Patient Registry]

The goal of the project is to build a clinical data research infrastructure that will begin to enhance capacity to use electronic health record (EHR) data and patient reported outcomes measures (PROs) to conduct opioid related research in emergency departments (EDs). 200 adult patients with a history of non-medical opioid use, opioid use disorder, or acute opioid overdose will be enrolled and will be asked to complete three PRO surveys (baseline, 3 days post ED discharge, and 30 days post discharge).